Zum Inhalt

A Clinicopathologic Study of Head and Neck Malignant Peripheral Nerve Sheath Tumors

  • 31.07.2017
  • Original Paper
Erschienen in:

Abstract

Head and neck high grade malignant peripheral nerve sheath tumors (HN-MPNSTs) are rare highly aggressive soft tissue sarcomas that show overlapping morphologic and immunophenotypic features with melanoma and other high grade sarcomas, resulting in diagnostic challenges, particularly in sporadic settings. Recent discoveries have implicated loss of function mutations in the polycomb repressive complex 2 (PRC2) components, including EED or SUZ12 genes, as one of the leading pathogenetic mechanisms in high grade MPNST. MPNSTs with PRC2 loss are associated with complete loss of trimethylation at lysine 27 of histone H3 (H3K27me3), which emerged as a reliable immunohistochemical marker in the diagnosis of sporadic and radiation induced MPNST. As the diagnosis of MPNST in the HN is particularly challenging to distinguish from melanoma and other sarcoma types, we carried out a clinicopathologic analysis on HN-MPNST patients managed at our institution over a 20-year period (1997–2016), using the latest diagnostic criteria including H3K27me3 staining and other molecular investigations. The overall survival of HN-MPNST was compared with other HN soft tissue sarcomas. The diagnosis of HN-MPNST was confirmed in 13 patients (seven males and six females), with a mean age of 31 years; with 3 (23%) patients being of pediatric age. The most common site was the neck soft tissue (77%). Two-thirds of patients (n = 9) had stigmata of NF1, three had prior radiotherapy and only one developed a de novo MPNST. All except one tumor (86%) tested showed loss of H3K27me3 expression, including all non-NF1 patients. The 2 and 5-year DSS rates were 50 and 30%. The 2-year DFS rate was 21%. Adverse predictors on DSS included adult age (p = 0.011), prior-history of RT (p = 0.003) and recurrence (p = 0.003). Compared to other molecularly confirmed subsets of HN sarcomas (Ewing and Ewing-like sarcoma, rhabdomyosarcoma and synovial sarcoma), HN-MPNST had the worst overall survival (p < 0.0001). We conclude that HN-MPNSTs are highly aggressive sarcomas associated with an unfavorable outcome and the utility of H3K27me3 IHC stains in the evaluation of MPNST is a reliable ancillary diagnostic adjunct.
Titel
A Clinicopathologic Study of Head and Neck Malignant Peripheral Nerve Sheath Tumors
Verfasst von
Adepitan A. Owosho
Cherry L. Estilo
Joseph M. Huryn
Ping Chi
Cristina R. Antonescu
Publikationsdatum
31.07.2017
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 2/2018
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-017-0841-y
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.

Neu im Fachgebiet Pathologie

Lymphome des Thymus und Mediastinums

Lymphozytenreiche Läsionen machen den Großteil der relevanten Differentialdiagnosen im vorderen Mediastinum aus und umfassen nichtneoplastische und neoplastische Entitäten. Lymphome stellen darunter mit ca. 10–15 % der Fälle eher einen kleinen …

Kombinationslymphome, Grauzonenlymphome und künftige Herausforderungen

Lymphome werden grundlegend in Hodgkin-Lymphome und B‑ und T‑Zell-Lymphome eingeteilt. Ihre Diagnostik beruht auf morphologischen, immunhistochemischen und zunehmend molekularen Methoden. Das klassische Hodgkin-Lymphom ist durch …

KI in der Diagnostik – aus Sicht der Pathologie

Die zunehmende Komplexität und Individualisierung onkologischer Diagnostik und Therapie stellt die Pathologie vor neue Herausforderungen. Gleichzeitig entwickelt sich die Künstliche Intelligenz (KI) von einer Zukunftstechnologie zu einem zentralen …

Räumlich-epidemiologische Datenanalyse von Pathologiedaten (REDPath)

In der pathologischen Routinediagnostik entstehen täglich große, gut dokumentierte Datensätze, deren Potential für räumlich-epidemiologische Analysen bislang kaum genutzt wird. Durch die Annotation dieser Daten eröffnen sich neue Möglichkeiten: …